NCITA is collaborating with clinical researchers across the UK to provide NCITA Repository, Imaging Clinical Trials Unit and QA/QC Unit support for multicentre clinical imaging biomarker studies.
NCITA infrastructure support is available to external partners from both academia and industry, provided the clinical research proposal meets the NCITA study eligibility criteria.
External Studies Adopted by the NCITA Infrastructure
NeuroSAFE PROOF Trial
A single blinded, multi-centre, feasibility study to evaluate the ability to randomise men with prostate cancer into a trial comparing NeuroSAFE Robotic assisted radical prostatectomy (RALP) to standard Robotic assisted radical prostatectomy (RALP).
NCITA Imaging Clinical Trials Unit, NCITA Repository Unit
Comparison of diagnostic ccuracy of Luminal Index and Multi-parametric MRI for Accelerated deTEction of significant prostate cancer
NCITA Imaging Clinical Trials Unit, QA/QC Unit, Repository Unit
Assessment of diagnostic and prognostic VALue, identification of bIological correlates, and Determination of TEchnical performance of novel metabolic and microstructural MRI in PROstate cancer
NCITA Imaging Clinical Trials Unit, Repository Unit
Lutathera and ASTX727 in Neuroendocrine Tumours
NCITA Imaging Clinical Trials Unit